By Mediplex Health Editor: Dr. Sharma, MD
In a recent breakthrough, FDA has approved a new device in the obesity treatment
This device is invented by Maestro Rechargeable System and it sends electrical signals to a critical nerve in the body known as vagus nerve. The function of this nerve to tell brain whether stomach is full or not. This device target the pathway between stomach and brain.
Technically, the system consists of a rechargeable electrical pulse generator, wire leads and electrodes implanted surgically into the abdomen.
Though device is found to be safe as per experts but their opinion remain divided about the efficacy of the device. Over 5 advisor were doubtful of its efficacy.
It will be used for the morbidly obese patients whose BMI is between 35 and 45 with associated clinical condition-type 2 diabetes. Mediplex Obesity experts evaluated the clinical trial data pertaining to this trial and found that trial was conducted on 233 patients with BMI greater than 35. The experimental group (157 patients) which recieved activated device lost 8.5 % more weight than the control group. The control group (76 patients) who recieved the non-activated device could not loose as much weight the experimental group.
The key conclusions of the study after 12 months: